Gocce Lassative Aicardi

Gocce Lassative Aicardi is a gastrointestinal product that contains the stimulant laxative sodium picosulfate as its active ingredient. The preparation is intended for oral administration, although the specific dosage form and strength are not disclosed. Marketed within the European Union, it belongs to the therapeutic class of laxatives and is used to promote bowel movements in adults.

Gocce Lassative Aicardi is indicated for the temporary relief of constipation and for bowel cleansing prior to certain diagnostic or therapeutic procedures. It may be employed in the following clinical situations:

- Short‑term treatment of functional constipation in adults. - Preparation of the colon before colonoscopy, sigmoidoscopy, or radiographic imaging. - Adjunct to surgical bowel preparation protocols. - Management of constipation associated with limited mobility or dietary changes. - Use in patients requiring rapid evacuation of the colon for medication administration.

Sodium picosulfate can cause a range of gastrointestinal and systemic effects, most of which are related to its stimulant action on the colon.

Common: - Abdominal cramping or discomfort. - Diarrhea or loose stools. - Increased frequency of bowel movements. - Nausea. - Mild electrolyte disturbances (e.g., low potassium).

Serious: - Severe dehydration. - Marked electrolyte imbalance (hypokalemia, hyponatremia). - Persistent abdominal pain. - Rectal bleeding. - Allergic reactions such as rash or swelling.

Before using Gocce Lassative Aicardi, consider the following safety points to minimize risks and ensure appropriate use:

- Verify that the product is suitable for short‑term use only; prolonged use may lead to dependence. - Assess renal or hepatic impairment, as altered metabolism may affect drug activity. - Use caution in patients with inflammatory bowel disease, intestinal obstruction, or severe abdominal pain. - Monitor fluid and electrolyte status, especially in elderly or frail individuals. - Pregnant or breastfeeding status is not well defined; consult a healthcare professional. - Ensure proper dosing instructions are followed to avoid excessive laxation.

Sodium picosulfate may interact with other medications or substances that influence fluid balance, electrolyte levels, or gastrointestinal motility.

Avoid: - Concurrent use with other stimulant or osmotic laxatives, which can increase the risk of severe dehydration. - Combination with diuretics or corticosteroids that may exacerbate electrolyte loss.

Use with caution: - Antacids containing magnesium, which can potentiate laxative effects. - Medications that prolong the QT interval, if significant electrolyte disturbances occur. - Oral rehydration solutions or electrolyte supplements, to maintain balance. - Herbal products with laxative properties, such as senna or cascara.